Month: February 2021

Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer

Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future salesAUSTIN, Texas,...

Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer

WILMETTE, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed...

Saint Peter’s University Hospital Expands Partnership with CarePort® to Support Compliance with CMS’s Patient Event Notification Requirements

New Jersey hospital selects CarePort Interop to deliver new electronic notifications to relevant stakeholders, gaining access to the nation’s largest...

error: Content is protected !!